We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+26.23%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$2.44B
AUM Growth
+$792M
Cap. Flow
+$442M
Cap. Flow %
18.15%
Top 10 Hldgs %
14.39%
Holding
5,222
New
2,059
Increased
1,821
Reduced
839
Closed
374

Sector Composition

Rank Sector Weight
1 Technology 12.14%
2 Healthcare 9.57%
3 Financials 8.79%
4 Industrials 7.76%
5 Consumer Discretionary 7.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MYOV
1251
DELISTED
Myovant Sciences Ltd.
MYOV
$379K 0.02%
18,387
+11,861
+182% +$161K
SUSA icon
1252
iShares ESG Optimized MSCI USA ETF
SUSA
$4.17B
$378K 0.02%
+5,658
New +$354K
APPF icon
1253
AppFolio
APPF
$7.05B
$377K 0.02%
+2,318
New +$303K
TFX icon
1254
Teleflex
TFX
$6B
$377K 0.02%
1,037
+611
+143% +$211K
GD icon
1255
General Dynamics
GD
$107B
$376K 0.02%
2,519
+1,801
+251% +$254K
GPC icon
1256
Genuine Parts
GPC
$18.5B
$374K 0.02%
4,306
+3,906
+977% +$308K
PEY icon
1257
Invesco High Yield Equity Dividend Achievers ETF
PEY
$1.16B
$374K 0.02%
25,878
-22,920
-47% -$323K
WW
1258
DELISTED
WW International
WW
$374K 0.02%
14,717
+11,205
+319% +$261K
FOXA icon
1259
Fox Class A
FOXA
$26.7B
$373K 0.02%
13,913
+13,842
+19,496% +$374K
SBIO icon
1260
ALPS Medical Breakthroughs ETF
SBIO
$215M
$373K 0.02%
8,914
-783
-8% -$30.9K
WLY icon
1261
John Wiley & Sons Class A
WLY
$2.64B
$373K 0.02%
9,573
+7,324
+326% +$280K
AEIS icon
1262
Advanced Energy
AEIS
$12.8B
$372K 0.02%
+5,478
New +$326K
ED icon
1263
Consolidated Edison
ED
$39.4B
$372K 0.02%
5,170
+2,564
+98% +$197K
SBH icon
1264
Sally Beauty Holdings
SBH
$1.55B
$372K 0.02%
29,665
+21,720
+273% +$238K
ALG icon
1265
Alamo Group
ALG
$2.04B
$371K 0.02%
+3,621
New +$347K
FRPT icon
1266
Freshpet
FRPT
$3.31B
$371K 0.02%
+4,427
New +$333K
MYY icon
1267
ProShares Short MidCap400
MYY
$2.89M
$371K 0.02%
9,425
-4,904
-34% -$213K
MED icon
1268
Medifast
MED
$140M
$370K 0.02%
2,663
+2,463
+1,232% +$226K
TDG icon
1269
TransDigm Group
TDG
$67.6B
$370K 0.02%
836
-795
-49% -$301K
TWST icon
1270
Twist Bioscience
TWST
$7.71B
$370K 0.02%
+8,164
New +$293K
HLT icon
1271
Hilton Worldwide
HLT
$70.6B
$369K 0.02%
5,030
+1,974
+65% +$147K
MKTX icon
1272
MarketAxess Holdings
MKTX
$5.72B
$369K 0.02%
737
-3,989
-84% -$1.86M
ARES icon
1273
Ares Management
ARES
$30.5B
$367K 0.02%
+9,240
New +$326K
KT icon
1274
KT
KT
$8.71B
$367K 0.02%
37,693
+6,619
+21% +$63.1K
KDMN
1275
DELISTED
Kadmon Holdings, Inc.
KDMN
$367K 0.02%
+71,623
New +$321K

Similar funds

Tower Research Capital (TRC)'s Q2 2020 Portfolio in Review

As of Q2 2020, Tower Research Capital (TRC) held 5,222 positions worth $2.44B, up 48% from $1.64B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Tower Research Capital (TRC) deployed $442M of net new capital in Q2 2020, opening 2,059 new positions and adding to 1,821 existing holdings. Its largest new stake was Apple: 428,252 shares worth $39.1M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 3.1% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $342M trimmed.

  • Tower Research Capital (TRC)'s largest Q2 2020 buy was Apple: 428,252 shares worth $39.1M.
  • Tower Research Capital (TRC) added most to iPath Series B S&P 500 VIX Short-Term Futures ETN in Q2 2020, an estimated $55.3M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $342M.
  • Tower Research Capital (TRC) fully exited First Trust Technology AlphaDEX Fund in Q2 2020, selling an estimated $2.52M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 14% of its $2.44B portfolio in Q2 2020.
  • Tower Research Capital (TRC) opened 2,059 new positions and closed 374 in Q2 2020.
  • Tower Research Capital (TRC)'s portfolio value rose 48% quarter-over-quarter to $2.44B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2020, filed 13 Aug 2020.